Modulation of CD20 expression in B-cell lymphomas treated with rituximab.

被引：0
|
作者：
Seliem, RM [1 ]
Freeman, JK [1 ]
Hasserjian, RP [1 ]
机构：
[1] Baystate Med Ctr, Springfield, MA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4787
引用
收藏
页码：311B / 311B
页数：1
相关论文
共 50 条
  • [1] Restoration of rituximab sensitivity in CD20 negative B-Cell lymphoma, cells; Epigenetic change of CD20 expression after treatment of rituximab.
    Tomita, Akihiro
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tornoki
    [J]. BLOOD, 2006, 108 (11) : 155B - 155B
  • [2] The predictive significance of CD20 expression in B-cell lymphomas
    Prevodnik, Veronika Kloboves
    Lavrencak, Jaka
    Horvat, Mateja
    Novakovic, Barbara Jezersek
    [J]. DIAGNOSTIC PATHOLOGY, 2011, 6
  • [3] The predictive significance of CD20 expression in B-cell lymphomas
    Veronika Kloboves Prevodnik
    Jaka Lavrenčak
    Mateja Horvat
    Barbara Jezeršek Novakovič
    [J]. Diagnostic Pathology, 6
  • [4] THE DIAGNOSTIC CHALLENGE OF RITUXIMAB-INDUCED CD20 NEGATIVE B-CELL LYMPHOMAS
    Risser, J.
    Breen, C.
    Feder, S.
    O'Leary, E.
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (01) : 159 - 159
  • [5] Transient downmodulation of CD20 by rituximab.
    Jilani, I
    O'Brien, S
    Manshouri, T
    Thomas, DA
    Thomazy, VA
    Imam, M
    Naeem, S
    Verstovsek, S
    Kantarjian, H
    Giles, F
    Keating, M
    Albitar, M
    [J]. BLOOD, 2002, 100 (11) : 804A - 804A
  • [6] Quantitative measurement of CD20 expression in chronic B-cell leukemias and lymphomas
    Huh, YO
    Keating, MJ
    Jilani, I
    Lerner, S
    Albitar, M
    [J]. CYTOMETRY, 2000, 42 (05): : 317 - 317
  • [7] Genetic and Epigenetic Modulation of CD20 Expression in B-Cell Malignancies: Molecular Mechanisms and Significance to Rituximab Resistance
    Tomita, Akihiro
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2016, 56 (02) : 89 - 99
  • [8] Loss of CD20 Expression and Exhaustion of Effector Cells Limit ADCC in CLL Patients Treated with Rituximab.
    Vire, Berengere
    Perry, Justin S. A.
    Lee, Elinor
    Stennett, Lawrence S.
    Samsel, Leigh
    McCoy, Philip
    Wilson, Wyndham H.
    Bielekova, Bibiana
    Wiestner, Adrian
    [J]. BLOOD, 2009, 114 (22) : 643 - 644
  • [9] Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas
    Yi, Jun Ho
    [J]. BLOOD RESEARCH, 2021, 56 : 1 - 4
  • [10] Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas
    Schuster, Stephen J.
    Huw, Ling-Yuh
    Bolen, Christopher R.
    Maximov, Victor
    Polson, Andrew G.
    Hatzi, Katerina
    Lasater, Elisabeth A.
    Assouline, Sarit E.
    Bartlett, Nancy L.
    Budde, L. Elizabeth
    Matasar, Matthew J.
    Koeppen, Hartmut
    Piccione, Emily C.
    Wilson, Deanna
    Wei, Michael C.
    Yin, Shen
    Penuel, Elicia
    [J]. BLOOD, 2024, 143 (09) : 822 - 832
12345